Elanco Animal Health (ELAN) Net Income towards Common Stockholders (QoQ) (2017 - 2026)
Powered by 
Analysis
Elanco Animal Health (ELAN) Net Income towards Common Stockholders (QoQ) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.52 Bn | 40.33 Bn | 779.09 Mn |
| 2 | Zoetis | 30.69 Bn | 29.02 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.89 Bn | 11.36 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 75.05 Mn | 67.96 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.26% |
| Mar 31, 2026 | 120.65% |
| Dec 31, 2025 | -711.76% |
| Sep 30, 2025 | -409.09% |
| Jun 30, 2025 | -83.58% |
| Mar 31, 2025 | 937.50% |
| Dec 31, 2024 | -102.20% |
| Sep 30, 2024 | 828.00% |
| Jun 30, 2024 | -256.25% |
| Mar 31, 2024 | 122.70% |
| Dec 31, 2023 | 87.14% |
| Sep 30, 2023 | -1,029.90% |
| Jun 30, 2023 | -194.17% |
| Mar 31, 2023 | 290.74% |
| Dec 31, 2022 | 16.92% |
| Sep 30, 2022 | -550.00% |
| Jun 30, 2022 | -119.61% |
| Mar 31, 2022 | 148.57% |
| Dec 31, 2021 | 2.78% |
| Sep 30, 2021 | 47.57% |